Vivo Capital, a California-based investment firm which backs healthcare companies in the U.S. and Greater China, has rounded up over US$1.28 billion for its ninth private equity fund, Vivo Capital Fund IX LP, according to the company’s latest regulatory filing with the SEC. The closing put the firm, which has offices in the U.S. and […] US, Greater China Healthcare-Focused Vivo Capital Garners $1.28B For Ninth PE Fund comes originally from China Money Network. All Rights Reserved.